Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179022-19-000022
Filing Date
2019-01-30
Accepted
2019-01-30 17:31:34
Documents
1
Period of Report
2019-01-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3015
  Complete submission text file 0001179022-19-000022.txt   4496
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12575 ULINE DRIVE PLEASANT PRAIRIE WI 53158
Business Address
LEWIS JOEL (Reporting) CIK: 0001725595 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 19552986